The sterilization equipment market is largely driven by increasing risks of cross-transmission in hospitals and other healthcare settings. According to a study conducted by Philip L. Russo et al., published in the Antimicrobial Resistance & Infection Control Journal, 2019, in Australia, the prevalence of patients with a hospital acquired infection (HAI) was 9.9%. The most common HAIs’ were surgical site infection, pneumonia, and urinary tract infection. The incidence is expected to be more in hospitals in developing and underdeveloped countries due to the lack of precautionary facilities. Other factors driving the growth of the market are the increasing number of surgical procedures, globally, primarily due to increasing number of chronic diseases and injuries. Additionally, due to the growth in the pharmaceutical industry, around the world, people are aware of sterilization equipment. These factors have also boosted the market growth. However, high stringent regulatory guidelines for market approval of devices and use of potentially harmful chemicals in these equipment have been restraining the market growth.

The global whole genome and exome sequencing market witnessed eight significant acquisitions during January 2017 to February 2020. All the acquisitions were aimed at the expansion of the product portfolio by acquiring sequencing-based portfolios with promising growth potential. Also, these acquisitions were intended to strengthen the existing product portfolio for improving accuracy and sensitivity of whole genome and exome sequencing methods. For instance, the acquisition of NEO Oncology AG by Siemens Healthineers, Inc. was aimed at expanding the company's portfolio to cater to the NGS-based molecular diagnostic market for cancer diagnosis and analysis. Further, Agilent Technologies, Inc. company acquired Population genetics for the development of IP portfolio which is aimed at improving accuracy and sensitivity of NGS detection.

Over the past few decades, viral and non-viral vectors are increasingly being used for the development of novel therapies. These vectors are helpful in achieving in-vivo delivery of gene to a targeted cell or tissue. Viral vectors such as adeno-associated virus, lentivirus, and retrovirus are some of the commonly used vectors utilized in several clinical and preclinical trials evaluating gene and cell therapy products as well as vaccines. For example, recombinant retroviruses are mostly used for the development of various gene therapies, targeting a number of genetic diseases, such as Marfan syndrome, hemochromatosis, Huntington’s disease, and sickle cell anemia. Retroviruses are mainly used to increase the expression of the genes and for easy chromosomal integration.

The global tumor genomics market represents the market scenario of the genomic technologies used for detection of various kinds of cancer across the world, taking into considerations of key established companies and their product contributions. The following chapter provides in-depth study of the factors affecting the growth of the tumor genomics market among different geographical regions. Market drivers, challenges or restraints are some of the factors that influence the market growth either by advancing or retarding the growth. Market opportunities are some of the factors for future growth of the market. Apart from these market dynamics, the following sections also describe the regulatory scenario of the global tumor genomics market that includes the approval and launches of various genomic products used for the identification of disease and analyzing the diseases conditions. Furthermore, this section also provides an overview of the competitive landscape that shows the key companies market share and their product offerings in the tumor genomics market. Following these sections, the report also covers the different market segmentation such as products, techniques, applications, end users, and cancer types. In addition, the region chapter enumerates the market scenario of different regions as well as different countries, their market dynamics and market size for each of the regions and countries as well. Furthermore, the company profiling section provides an overview of the key companies, SWOT, financials (for public companies), and their products offerings pertaining to global tumor genomics market

The Polymeric Biomaterials market is largely driven by increasing global prevalence of chronic diseases and technological advancements in the polymeric biomaterials as this chronic diseases will increase the demand for polymer biomaterial based products resulting into high growth of the market As per the World Health Organization (WHO), it is estimated that there will be 23.6 million deaths annually by 2030, due to CVD, with the largest increase in Southeast Asia. The factors, such as innovations in polymeric biomaterials and increasing number of applications of polymeric biomaterials in tissue engineering, are expected to fuel the growth of the market studied, over the forecast period. But factors, like bio-compatibility issues in biomaterials (especially in implanted/ingested materials) and stringent regulations for certain polymeric biomaterials, are expected to limit the growth of the market.

本次募集资金主要用于：商家服务、支付出海及科技赋能。根据蚂蚁集团招股书，本次募集资金将主要用于进一步支持 创新、科技的投入，助力数字经济转型、补充流动资金及加强全球合作。在助力数字经济升级方面，募集资金将重点用 于用户与商家服务和产品的持续创新，推动金融服务及日常生活服务的数字化升级；在加强全球合作并助力全球可持续 发展方面，募集资金将重点用于跨境支付能力的建设，加强与国际伙伴的合作，拓展海外用户和商户基础；在支持创新 和科技方面，募集资金将重点用于人工智能、风险管理、安全、区块链、物联网、计算及技术基础设施等核心技术领域 的研发创新投入，以及与之对应的人才队伍的培养和建设。

The report covers all the revenue generated by the direct-fed microbial used in animal husbandry as well as for pet keeping. Direct-fed microbial are used to assist in digestion of feed in various animals. This helps to maintain the better health of animals and helps to increase the profitability of the animal husbandry business. The report considers the revenue generated by livestock and type of probiotics used. Moreover, it analyzes the current market trends of direct fed microbial across different regions, including North America, Europe, Asia-Pacific, and LAMEA.

Digital forensic has been growing from addressing minor computer crimes to the investigation of complex international cases with a massive effect on the world. Digital forensics includes the recovery and investigation of material found in digital devices, often in relation to computer crime. Digital forensics investigations have many applications. The world is now wholly dependent on digital devices, and this space is continuously evolving. Although most forensics have been oriented toward the desktops, laptops, and the associated media, including the hard drive, floppy disk, and optical discs, other forms of digital forensics, such as mobile phones and other handheld devices are increasingly becoming popular for digital curation and preservation. The smartphone industry has been steadily developing and growing, both in market size, as well as in suppliers and models. Moreover, technologies, such as IoT and cloud, are profoundly penetrating the IT space defining the future of the cyber world.